Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Vytorin

FDA fails to approve cholesterol drug for kidney disease

U.S. health regulators amended the prescribing label for Merck & Co’s cholesterol-lowering drug Vytorin to show it prevents heart problems in patients with chronic kidney disease, but stopped short of approving its use for that purpose.

The decision means Merck cannot market Vytorin as a treatment for reducing the rate of heart problems in… FDA fails to approve cholesterol drug for kidney disease   



overweight1 - pharmaceutical science1 - oxalate4 - incontinence10 - dry mouth1 - diet1 - risk of kidney stones1 - ureteral edema1 - cancer2 - shaft1 - tea1 - chemotherapy12 - artificial urinary sphincter1 - renal calculi1 - hair loss1 - beta-blockers1 - nvasive follow-up tests1 - ccrcc1 - risks of impotence1 - rectocele5 - estradiol deficiency1 - national cancer institute1 - internal genitalia1 - uterine cancer2 - patient care1 - abdominal pain2 - astro3 - testis-determining gene1 - advanced ckd1 - ket1 -